Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited progressive neurological disorder characterized by neuronal degeneration and reactive gliosis in the cerebellum, brainstem, spinocerebellar tracts, and dorsal columns. Multiple system atrophy is a sporadic progressive neurological disorder with degeneration and gliosis in the basal ganglia, cerebellum, brainstem, and spinal autonomic nuclei, and with argyrophilic glial cytoplasmic inclusions. We describe 4 members of a family with the SCAl mutation and a dominantly inherited progressive ataxia in which autopsy examination of 1 member showed neuropathological changes typical of multiple system atrophy, including glial cytoplasmic inclusions. In this patient, magnetic resonance imaging revealed marked brainstem and cerebellar volume loss and mild supratentorial generalized volume loss. Positron emission tomography with [18F]fluorodeoxyglucose revealed widespread hypometabolism in a pattern found in sporadic multiple system atrophy and not in dominantly inherited olivopontocerebellar atrophy. Positron emission tomography with [llC]flumazenil revealed normal benzodiazepine receptor distribution volumes, similar to those seen in sporadic multiple system atrophy. Two other family members still living had similar changes in the imaging studies. The findings in this family suggest that the SCAl gene mutation can result in a disorder similar to multiple system atrophy, both clinically and neuropathologically.

[1]  R. Currier,et al.  Spinocerebellar ataxia , 1972, Neurology.

[2]  J. Weber,et al.  Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23–24.1 , 1993, Nature Genetics.

[3]  J. Goud,et al.  Transferrin, haptoglobin and group-specific component types in tribal populations of Andhra Pradesh. , 1980, Human heredity.

[4]  P. Mcgeer,et al.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue , 1992, Neuroscience Letters.

[5]  P. Lantos,et al.  Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy , 1992, Journal of the Neurological Sciences.

[6]  B. Woods,et al.  Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity. , 1972, Journal of the neurological sciences.

[7]  C. Andrade,et al.  Autosomal dominant system degeneration in Portuguese families of the Azores Islands , 1978, Neurology.

[8]  S. Gilman,et al.  Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings , 1988, Annals of neurology.

[9]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  R. Currier,et al.  Morphometric studies in dominant olivopontocerebellar atrophy. Comparison of cell losses with amino acid decreases. , 1990, Archives of neurology.

[11]  H. Yamaguchi,et al.  Oligodendroglial Microtubular Tangles in Olivopontocerebellar Atrophy , 1990, Journal of neuropathology and experimental neurology.

[12]  X. Estivill,et al.  Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred , 1995, Neurology.

[13]  R A Koeppe,et al.  Alternative Approach to Single-Scan Estimation of Cerebral Glucose Metabolic Rate Using Glucose Analogs, with Particular Application to Ischemia , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  S. Gilman,et al.  Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy , 1994, Annals of neurology.

[15]  R. Hichwa,et al.  Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography , 1988, Annals of neurology.

[16]  A. Harding The hereditary ataxias and related disorders , 1984 .

[17]  R. Koeppe,et al.  Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.

[18]  G M SHY,et al.  A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. , 1960, Archives of neurology.

[19]  F. Persichetti,et al.  HLA‐linked spinocerebellar ataxia: a clinical and genetic study of large Italian kindreds , 1992, Acta neurologica Scandinavica.

[20]  D E Kuhl,et al.  Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]Flumazenil , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  W. Dixon,et al.  BMDP statistical software , 1983 .

[22]  L Junck,et al.  Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography , 1988, Annals of neurology.

[23]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[24]  Sid Gilman,et al.  Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography , 1995, Annals of neurology.

[25]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[26]  J. Bloedel,et al.  Disorders of the cerebellum , 1981 .

[27]  J. Blaivas Management of bladder dysfunction in multiple sclerosis , 1980, Neurology.

[28]  D E Kuhl,et al.  Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  H. Zoghbi,et al.  Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado‐Joseph disease , 1995, Annals of neurology.

[30]  C D Marsden,et al.  Neurology Neurosurgery & Psychiatry Editorial the Motor Disorder of Multiple System Atrophy , 2022 .

[31]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[32]  P. Lantos,et al.  Cellular pathology of multiple system atrophy: a review. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[33]  H. Orr,et al.  Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11 , 1994, Nature Genetics.

[34]  R. Duvoisin,et al.  The Olivopontocerebellar Atrophies , 1982 .

[35]  B. Konigsmark,et al.  THE OLIVOPONTOCEREBELLAR ATROPHIES: A REVIEW , 1970, Medicine.

[36]  Josep Maria Salanova Grau,et al.  HIV or zidovudine myopathy? , 1994, Neurology.

[37]  P. Lantos,et al.  The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. , 1994, Brain : a journal of neurology.

[38]  C. D'amato,et al.  Fulminant multiple system atrophy in a young adult presenting as motor neuron disease , 1993, Neurology.